{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:52Z","timestamp":1777984372029,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02222-0","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:16:41Z","timestamp":1772867801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of serum androgen levels with Framingham Cardiovascular Risk Score in individuals with obesity"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9281-1771","authenticated-orcid":false,"given":"Banu Betul","family":"Kocaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5091-9160","authenticated-orcid":false,"given":"Feray","family":"Akbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"2222_CR1","first-page":"1","volume":"894","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1\u2013253.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"7","key":"2222_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40273-014-0243-x","volume":"33","author":"A Hruby","year":"2015","unstructured":"Hruby A, Hu FB. The epidemiology of obesity: a big picture. PharmacoEconomics. 2015;33(7):673\u201389.","journal-title":"PharmacoEconomics"},{"issue":"10431","key":"2222_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027\u201350.","journal-title":"Lancet"},{"issue":"11","key":"2222_CR4","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMsr043743","volume":"352","author":"SJ Olshansky","year":"2005","unstructured":"Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138\u201345.","journal-title":"N Engl J Med"},{"issue":"8","key":"2222_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJMoa055643","volume":"355","author":"KF Adams","year":"2006","unstructured":"Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763\u201378.","journal-title":"N Engl J Med"},{"issue":"9669","key":"2222_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"S Lewington","year":"2009","unstructured":"Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083\u201396.","journal-title":"Lancet"},{"issue":"9793","key":"2222_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(11)60814-3","volume":"378","author":"YC Wang","year":"2011","unstructured":"Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815\u201325.","journal-title":"Lancet"},{"issue":"7","key":"2222_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.115.016801","volume":"133","author":"D Aune","year":"2016","unstructured":"Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose\u2013response meta-analysis of prospective studies. Circulation. 2016;133(7):639\u201349.","journal-title":"Circulation"},{"issue":"18","key":"2222_CR9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837\u201347.","journal-title":"Circulation"},{"key":"2222_CR10","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/jcem.87.8.8762","volume":"87","author":"AE Hak","year":"2002","unstructured":"Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam Study. J Clin Endocrinol Metab. 2002;87:3632\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2222_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.maturitas.2013.04.012","volume":"75","author":"V Soisson","year":"2013","unstructured":"Soisson V, Brailly-Tabard S, Helmer C, Rouaud O, Ancelin ML, Zerhouni C, et al. A J-shaped association between plasma testosterone and risk of ischemic arterial events in elderly men: the French 3\u00a0C cohort study. Maturitas. 2013;75(3):282\u20138.","journal-title":"Maturitas"},{"issue":"5","key":"2222_CR12","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/cen.12452","volume":"81","author":"MM Shores","year":"2014","unstructured":"Shores MM, Arnold AM, Biggs ML, Longstreth WT Jr, Smith NL, Kizer JR, et al. Testosterone and dihydrotestosterone and incident ischaemic stroke in men. Clin Endocrinol (Oxf). 2014;81(5):746\u201353.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2222_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/01.CIR.89.1.89","volume":"89","author":"LE Mitchell","year":"1994","unstructured":"Mitchell LE, Sprecher DL, Borecki IB, Rice T, Laskarzewski PM, Rao DC. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation. 1994;89(1):89\u201393.","journal-title":"Circulation"},{"issue":"17","key":"2222_CR14","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.jacc.2014.05.076","volume":"64","author":"\u00c5 Tivesten","year":"2014","unstructured":"Tivesten \u00c5, Vandenput L, Carlzon D, Nilsson M, Karlsson MK, Ljunggren \u00d6, et al. Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men. J Am Coll Cardiol. 2014;64(17):1801\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2222_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1532-5415.2010.02724.x","volume":"58","author":"JL Sanders","year":"2010","unstructured":"Sanders JL, Boudreau RM, Cappola AR, Arnold AM, Robbins J, Cushman M, et al. Cardiovascular disease is associated with greater incident dehydroepiandrosterone sulfate decline in the oldest old. J Am Geriatr Soc. 2010;58(3):421\u20136.","journal-title":"J Am Geriatr Soc"},{"key":"2222_CR16","unstructured":"World Health Organization. Obesity and overweight. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 1 Mar 2024."},{"issue":"1","key":"2222_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejcn.2009.139","volume":"64","author":"C Nishida","year":"2010","unstructured":"Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on waist circumference and waist\u2013hip ratio. Eur J Clin Nutr. 2010;64(1):2\u20135.","journal-title":"Eur J Clin Nutr"},{"issue":"Suppl 1","key":"2222_CR18","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142019. Diabetes Care. 2019;42(Suppl 1):S13\u201328.","journal-title":"Diabetes Care"},{"issue":"12","key":"2222_CR19","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"1","key":"2222_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje.0.1510001","volume":"151","author":"A Tchernof","year":"2004","unstructured":"Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol. 2004;151(1):1\u201314.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2222_CR21","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/1440-1681.13146","volume":"46","author":"TT Wu","year":"2019","unstructured":"Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Association of endogenous DHEA\/DHEAS with coronary heart disease: a systematic review and meta-analysis. Clin Exp Pharmacol Physiol. 2019;46(11):984\u201394.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"12","key":"2222_CR22","doi-asserted-by":"publisher","first-page":"e4304","DOI":"10.1210\/clinem\/dgaa518","volume":"105","author":"X Jia","year":"2020","unstructured":"Jia X, Sun C, Tang O, Gorlov I, Nambi V, Virani SS, et al. Plasma dehydroepiandrosterone sulfate and cardiovascular disease risk in older men and women. J Clin Endocrinol Metab. 2020;105(12):e4304\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2222_CR23","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.jacc.2018.01.083","volume":"71","author":"D Zhao","year":"2018","unstructured":"Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, et al. Endogenous sex hormones and incident cardiovascular disease in postmenopausal women. J Am Coll Cardiol. 2018;71(22):2555\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"2222_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/joe.0.1500149","volume":"150","author":"KT Khaw","year":"1996","unstructured":"Khaw KT. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J Endocrinol. 1996;150:149\u201353.","journal-title":"J Endocrinol"},{"issue":"1","key":"2222_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00109-019-01842-5","volume":"98","author":"CJ Teixeira","year":"2020","unstructured":"Teixeira CJ, Veras K, de Oliveira Carvalho CR. Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period. J Mol Med (Berl). 2020;98(1):39\u201357.","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"2222_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.111.086660","volume":"126","author":"K Kappert","year":"2012","unstructured":"Kappert K, B\u00f6hm M, Schmieder R, Schumacher H, Teo K, Yusuf S, et al. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk. Circulation. 2012;126(8):934\u201341.","journal-title":"Circulation"},{"issue":"9819","key":"2222_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0140-6736(11)61453-0","volume":"379","author":"FJ Charchar","year":"2012","unstructured":"Charchar FJ, Bloomer LD, Barnes TA, Cowley MJ, Nelson CP, Wang Y, et al. Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet. 2012;379(9819):915\u201322.","journal-title":"Lancet"},{"key":"2222_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0008-6363(00)00005-5","volume":"46","author":"CS Hayward","year":"2000","unstructured":"Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res. 2000;46:28\u201349.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"2222_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.7326\/M23-2781","volume":"177","author":"BB Yeap","year":"2024","unstructured":"Yeap BB, Marriott RJ, Dwivedi G, Adams RJ, Antonio L, Ballantyne CM, et al. Associations of testosterone and related hormones with all-cause and cardiovascular mortality and incident cardiovascular disease in men. Ann Intern Med. 2024;177(6):768\u201381.","journal-title":"Ann Intern Med"},{"key":"2222_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/cen.12013","volume":"78","author":"R Haring","year":"2013","unstructured":"Haring R, Teng Z, Xanthakis V, Coviello A, Sullivan L, Bhasin S, et al. Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men. Clin Endocrinol (Oxf). 2013;78:629\u201334.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2222_CR31","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"LJ Shaw","year":"2008","unstructured":"Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women\u2019s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93(4):1276\u201384. Epub 2008 Jan 8. Retraction in: J Clin Endocrinol Metab. 2015;100(3):1206.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2222_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa030808","volume":"349","author":"JE Manson","year":"2003","unstructured":"Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349(6):523\u201334.","journal-title":"N Engl J Med"},{"key":"2222_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.amjmed.2005.09.059","volume":"118","author":"ML Stefanick","year":"2005","unstructured":"Stefanick ML. Estrogens and progestins: background and history, trends in use, and guidelines approved by the US Food and Drug Administration. Am J Med. 2005;118:64\u201373.","journal-title":"Am J Med"},{"issue":"2","key":"2222_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/ATVBAHA.114.304821","volume":"35","author":"M Benn","year":"2015","unstructured":"Benn M, Voss SS, Holmegard HN, Jensen GB, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Arterioscler Thromb Vasc Biol. 2015;35(2):471\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"2222_CR35","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1161\/01.CIR.0000091114.36254.F3","volume":"108","author":"KM Rexrode","year":"2003","unstructured":"Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108(14):1688\u201393.","journal-title":"Circulation"},{"issue":"7014","key":"2222_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/bmj.311.7014.1193","volume":"311","author":"E Barrett-Connor","year":"1995","unstructured":"Barrett-Connor E, Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ. 1995;311(7014):1193\u20136.","journal-title":"BMJ"},{"issue":"3","key":"2222_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1365-2265.1998.00533.x","volume":"49","author":"Y Yamaguchi","year":"1998","unstructured":"Yamaguchi Y, Tanaka S, Yamakawa T, Kimura M, Ukawa K, Yamada Y, et al. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin Endocrinol (Oxf). 1998;49(3):377\u201383.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9669","key":"2222_CR38","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"G Whitlock","year":"2009","unstructured":"Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults. Lancet. 2009;373(9669):1083\u201396.","journal-title":"Lancet"},{"issue":"1","key":"2222_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0021-9150(99)00055-6","volume":"144","author":"H Schulte","year":"1999","unstructured":"Schulte H, Cullen P, Assmann G. Obesity, mortality and cardiovascular disease in the M\u00fcnster Heart Study (PROCAM). Atherosclerosis. 1999;144(1):199\u2013209.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2222_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-022-01670-x","volume":"21","author":"T Qiao","year":"2022","unstructured":"Qiao T, Luo T, Pei H, Yimingniyazi B, Aili D, Aimudula A, et al. Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):225.","journal-title":"Cardiovasc Diabetol"},{"key":"2222_CR41","doi-asserted-by":"publisher","first-page":"1284144","DOI":"10.3389\/fendo.2024.1284144","volume":"15","author":"Y Ren","year":"2024","unstructured":"Ren Y, Hu Q, Li Z, Zhang X, Yang L, Kong L. Dose\u2013response association between Chinese visceral adiposity index and cardiovascular disease. Front Endocrinol (Lausanne). 2024;15:1284144.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2222_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.7326\/M14-2525","volume":"163","author":"KR Sahakyan","year":"2015","unstructured":"Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, et al. Normal-weight central obesity and cardiovascular mortality. Ann Intern Med. 2015;163(11):827\u201335.","journal-title":"Ann Intern Med"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02222-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02222-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02222-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:18:35Z","timestamp":1776176315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02222-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02222-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8702626\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Academic Board of the Faculty of Medicine, Health Sciences University, with decision number 184 on March 27, 2019, and by the Clinical Research Ethics Committee of Istanbul Training and Research Hospital with decision number 1799 on April 26, 2019. The research was carried out in adherence to the ethical guidelines outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}